The FDA announced this week that it is limiting use of two monoclonal antibody drugs for Covid that do not work against the Omicron variant — a step that many thought was overdue. Acting FDA Commissioner Janet Woodcock spoke with STAT about what comes next for the regulation of Covid drugs and vaccines.
This interview has been edited for clarity. Read the rest…